Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0776
-0.0024 (-3.00%)
Sep 25, 2026, 4:39 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 95.26 million as of September 25, 2026. Its market cap has decreased by -36.65% in one year.
Market Cap
95.26M
Enterprise Value
105.97M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
ChartMarket Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 95.26M, a decrease of -87.58%. That is a compound annual growth rate of -44.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 95.26M | -16.92% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.12T |
| Genmab | 136.42B |
| Coloplast | 94.71B |
| Demant | 64.49B |
| Gubra | 4.97B |
| BioPorto | 554.52M |
| ViroGates | 93.75M |
| Scandinavian Medical Solutions | 69.52M |